Home › Islet Cell Adenoma › Nebraska › Omaha
Islet Cell Adenoma clinical trials in Omaha, NE
3 studies for Islet Cell Adenoma are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- University of Nebraska Medical Center, Omaha
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
RecruitingPhase 3
- Research Facility, Omaha
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
RecruitingPhase 2
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
- and 1 more
Islet Cell Adenoma trials in other cities
- Rochester, MN5 studies
- Los Angeles, CA5 studies
- St. Louis, MO5 studies
- Phoenix, AZ4 studies
- Portland, OR4 studies
- Washington, DC4 studies
- Columbus, OH4 studies
- Salt Lake City, UT4 studies
- Lexington, KY4 studies
- Chicago, IL4 studies
- Jacksonville, FL3 studies
- Irvine, CA3 studies
Other studies in Omaha
- Prostate Cancer27 studies
- Non-Small Cell Lung Cancer24 studies
- Breast Cancer22 studies
- Colorectal Cancer18 studies
- Cancer (all types)18 studies
- Multiple Myeloma16 studies
- Non-Hodgkin Lymphoma14 studies
- Ovarian Cancer14 studies
- Pancreatic Cancer14 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Heart Failure13 studies
- Metastatic Cancer13 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.